Fundraising Fox
Digma Medical
4 known investors
Find your way into Digma Medical
Sign up to see every warm intro you have to Digma Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Digma Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Digma Medical develops the Endoscopic Gastrointestinal Ablation Device (EGAD), a minimally invasive therapy using a console and single-use catheter for contactless, imaging-guided ablation of esophageal mucosal tissue, initially targeting Barrett's Esophagus. The device is designed for use in standard GI endoscopy suites and serves gastroenterology clinicians treating pre-cancerous and other GI pathologies.
Investors · 4
How we know: Accelmed Partners's portfolio page · Not right? Tell us
How we know: Incentive, Peregrine Ventures Incubator's portfolio page · Not right? Tell us
How we know: Peregrine Ventures's portfolio page · Not right? Tell us
How we know: Tal Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
Founder mafia
3 people who came through Digma Medical went on to found or lead other companies.
In the news
Frequently asked questions
- What does Digma Medical do?
- Digma Medical develops the Endoscopic Gastrointestinal Ablation Device (EGAD), a minimally invasive therapy using a console and single-use catheter for contactless, imaging-guided ablation of esophageal mucosal tissue, initially targeting Barrett's Esophagus. The device is designed for use in standard GI endoscopy suites and serves gastroenterology clinicians treating pre-cancerous and other GI pathologies.
- Who are Digma Medical's investors?
- Digma Medical's investors include Accelmed Partners, Incentive, Peregrine Ventures Incubator, Peregrine Ventures, Tal Ventures.